Advanz Pharma Uk And Ireland Limited
09793586
Healthy
- No accounts filed in last 18 months (-5)
- 1 outstanding charge (-2)
Details
Compliance
Last accounts
31/12/2024
full
Next accounts due
30/09/2026
Confirmation statement
Last: 30/09/2025
Due 14/10/2026
Industry
Officers
director · Since 23/02/2024
VICE PRESIDENT UK&I
BRITISH · ENGLAND · Age 53
Also on 1 other board
director · Since 06/02/2025
VICE PRESIDENT, STRATEGIC FINANCE
BRITISH · ENGLAND · Age 44
Also on 6 other boards
Persons with Significant Control
Mercury Pharma Group Limited
Dashwood House, 69 Old Broad Street, London, EC2M 1QS
Reg: 02330913 · Companies House · Private Limited Company
Notified 01/07/2022
Former PSCs
Intercept Pharmaceuticals, Inc.
Ceased 01/07/2022
Charges1 outstanding
Glas Trust Corporation Limited as Security Agent and Security Trustee for the Benefit of the Secured Parties (As Defined in the Instrument)
CompanyRankvs 381+ SIC 46460 peers66
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2023
Turnover
£14.1M
Annual revenue
Net Worth
£5.1M
Balance sheet strength
Cash
£1.8M
Cash in the bank
Profit Before Tax
£448k
Bottom line earnings
Net Current Assets
£7.0M
Working capital
Current Assets
£35.8M
Current Liabilities
£28.8M
Fixed Assets
£0
Debtors
£33.6M
Cost of Sales
£411k
Gross Profit
£13.7M
Admin Expenses
£12.0M
Operating Profit
£448k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2023 | 1.24 |
Derived from filed accounts. Not audited figures.